Trevi Therapeutics CEO Jennifer Good's 2019 pay jumps 432% to $2.8M
Trevi Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
Trevi Therapeutics reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, three executives at Trevi Therapeutics received on average a compensation package of $1.5M, a 95% increase compared to previous year.
Average pay of disclosed executives at Trevi Therapeutics
Jennifer Good, Chief Executive Officer, received $2.8M in total, which increased by 432% compared to 2018. 79% of Good's compensation, or $2.2M, was in option awards. Good also received $145K in bonus, $435K in salary, as well as $8.4K in other compensation.
Yann Mazabraud, Chief Commercial Officer and Head of International, received a compensation package of $915K, which decreased by 10% compared to previous year. 39% of the compensation package, or $359K, was in option awards.
Thomas Sciascia, Chief Medical Officer, earned $787K in 2019.
Related executives
You may also like
Source: SEC filing on April 29, 2020.